OIG PROBE OF HOSPITAL BILLING FOR UNAPPROVED DEVICES; INQUIRY YIELDS ONE CRIMINAL INVESTIGATION, ONE SETTLEMENT TO DATE; SEN. ROTH WROTH OVER PACE OF INQUIRY
This article was originally published in The Gray Sheet
Executive SummaryThe HHS Inspector General's probe into Medicare and Medicaid billing for unapproved devices by hospitals has yielded one criminal investigation thus far out of the 132 subpoenas issued, Deputy Inspector General Jack Hartwig told the Senate Governmental Affairs/Investigations Subcommittee at a Feb. 14 hearing.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.